These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1934454)

  • 21. Axonal neuropathy in eosinophilia-myalgia syndrome.
    Burns SM; Lange DJ; Jaffe I; Hays AP
    Muscle Nerve; 1994 Mar; 17(3):293-8. PubMed ID: 8107705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophilia-myalgia syndrome in L-tryptophan-exposed patients.
    Kamb ML; Murphy JJ; Jones JL; Caston JC; Nederlof K; Horney LF; Swygert LA; Falk H; Kilbourne EM
    JAMA; 1992 Jan; 267(1):77-82. PubMed ID: 1727200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eosinophilic fasciitis associated with tryptophan ingestion. A manifestation of eosinophilia-myalgia syndrome.
    Gordon ML; Lebwohl MG; Phelps RG; Cohen SR; Fleischmajer R
    Arch Dermatol; 1991 Feb; 127(2):217-20. PubMed ID: 1990986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcinosis cutis in a patient with eosinophilia-myalgia syndrome: case report.
    Smith E; Gordon M; Lebwohl M
    Cutis; 2006 Jun; 77(6):361-4. PubMed ID: 16838769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Demyelinating nervous lesions in myalgia-eosinophilia syndrome induced by L Tryptophan].
    Labauge P; Moulonguet A; Penaud D; Lessana-Leibowitch M; Kahn MF; Said G
    Rev Neurol (Paris); 1993; 149(4):278-82. PubMed ID: 8235226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan.
    Henning KJ; Jean-Baptiste E; Singh T; Hill RH; Friedman SM
    J Rheumatol; 1993 Feb; 20(2):273-8. PubMed ID: 8474064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of L-tryptophan and an illness resembling eosinophilic fasciitis. Clinical and histopathologic findings in four patients with eosinophilia-myalgia syndrome.
    Bulpitt KJ; Verity MA; Clements PJ; Paulus HE
    Arthritis Rheum; 1990 Jul; 33(7):918-29. PubMed ID: 2369428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Kaufman LD; Krupp LB
    Curr Opin Rheumatol; 1995 Nov; 7(6):560-7. PubMed ID: 8579979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The eosinophilia-myalgia syndrome: current concepts and future directions.
    Kaufman LD
    Clin Exp Rheumatol; 1992; 10(1):87-91. PubMed ID: 1551286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset.
    Hertzman PA; Clauw DJ; Kaufman LD; Varga J; Silver RM; Thacker HL; Mease P; Espinoza LR; Pincus T
    Ann Intern Med; 1995 Jun; 122(11):851-5. PubMed ID: 7741371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eosinophilia-myalgia syndrome. Natural history in a population-based cohort.
    Hedberg K; Urbach D; Slutsker L; Matson P; Fleming D
    Arch Intern Med; 1992 Sep; 152(9):1889-92. PubMed ID: 1520057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eosinophilia-myalgia syndrome (L-tryptophan-associated neuromyopathy).
    Turi GK; Solitare GB; James N; Dicker R
    Neurology; 1990 Nov; 40(11):1793-6. PubMed ID: 2234439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology.
    Martin RW; Duffy J; Engel AG; Lie JT; Bowles CA; Moyer TP; Gleich GJ
    Ann Intern Med; 1990 Jul; 113(2):124-34. PubMed ID: 2360751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eosinophilia-myalgia syndrome associated with L-tryptophan. A case report with pulmonary manifestations and review of the literature.
    André M; Canon JL; Levecque P; Dermine P; Mortier C; Leveau F
    Acta Clin Belg; 1991; 46(3):178-82. PubMed ID: 1656679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eosinophilia-myalgia syndrome due to L-tryptophan ingestion. Report of four cases and review of the Maryland experience.
    Roubenoff R; Coté T; Watson R; Levin ML; Hochberg MC
    Arthritis Rheum; 1990 Jul; 33(7):930-8. PubMed ID: 2369429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eosinophilia-myalgia syndrome and fasciitis with an active alveolitis.
    Chauhan D; Mengel CE
    Kans Med; 1993 Jun; 94(6):175-7. PubMed ID: 8355447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer.
    Slutsker L; Hoesly FC; Miller L; Williams LP; Watson JC; Fleming DW
    JAMA; 1990 Jul; 264(2):213-7. PubMed ID: 2355442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromuscular manifestations of L-tryptophan-associated eosinophilia-myalgia syndrome: a histomorphologic analysis of 14 patients.
    Verity MA; Bulpitt KJ; Paulus HE
    Hum Pathol; 1991 Jan; 22(1):3-11. PubMed ID: 1985074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eosinophilia in Rheumatologic/Vascular Disorders.
    Tamaki H; Chatterjee S; Langford CA
    Immunol Allergy Clin North Am; 2015 Aug; 35(3):453-76. PubMed ID: 26209895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan.
    Allen JA; Peterson A; Sufit R; Hinchcliff ME; Mahoney JM; Wood TA; Miller FW; Whitfield ML; Varga J
    Arthritis Rheum; 2011 Nov; 63(11):3633-9. PubMed ID: 21702023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.